BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24989170)

  • 41. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Zhu FC; Meng FY; Li JX; Li XL; Mao QY; Tao H; Zhang YT; Yao X; Chu K; Chen QH; Hu YM; Wu X; Liu P; Zhu LY; Gao F; Jin H; Chen YJ; Dong YY; Liang YC; Shi NM; Ge HM; Liu L; Chen SG; Ai X; Zhang ZY; Ji YG; Luo FJ; Chen XQ; Zhang Y; Zhu LW; Liang ZL; Shen XL
    Lancet; 2013 Jun; 381(9882):2024-32. PubMed ID: 23726161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.
    Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY
    Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.
    Cheng A; Fung CP; Liu CC; Lin YT; Tsai HY; Chang SC; Chou AH; Chang JY; Jiang RH; Hsieh YC; Su IJ; Chong PC; Hsieh SM
    Vaccine; 2013 May; 31(20):2471-6. PubMed ID: 23541623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children.
    Zhang Y; Wang L; Liao Y; Liu L; Ma K; Yang E; Wang J; Che Y; Jiang L; Pu J; Guo L; Feng M; Liang Y; Cui W; Yang H; Li Q
    Vaccine; 2015 Nov; 33(46):6290-7. PubMed ID: 26419198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
    Yan Q; Wu L; Chen L; Qin Y; Pan Z; Chen M
    Vaccine; 2016 Jul; 34(35):4196-4204. PubMed ID: 27373596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial.
    Zhang W; Kong Y; Jiang Z; Li C; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Apr; 12(4):922-30. PubMed ID: 26837471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice.
    Pathinayake PS; Gayan Chathuranga WA; Lee HC; Chowdhury MYE; Sung MH; Lee JS; Kim CJ
    Arch Virol; 2018 Aug; 163(8):2073-2083. PubMed ID: 29619599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coxsackievirus A 16 infection does not interfere with the specific immune response induced by an enterovirus 71 inactivated vaccine in rhesus monkeys.
    Wang J; Qi S; Zhang X; Zhang Y; Liu L; Che Y; He Z; Zhao Y; Lu S; Yu W; Li Q
    Vaccine; 2014 Jul; 32(35):4436-4442. PubMed ID: 24958699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.
    Wang M; Jiang S; Wang Y
    Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.
    Shao J; Zhang J; Wu X; Mao Q; Chen P; Zhu F; Xu M; Kong W; Liang Z; Wang J
    PLoS One; 2015; 10(10):e0140515. PubMed ID: 26465882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
    Tambyah PA; Oon J; Asli R; Kristanto W; Hwa SH; Vang F; Karwal L; Fuchs J; Santangelo JD; Gordon GS; Thomson C; Rao R; Dean H; Das SC; Stinchcomb DT
    Vaccine; 2019 Jul; 37(31):4344-4353. PubMed ID: 31230881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys].
    Zhang XM; Zhao HL; Wang JJ; Liao Y; Na RX; Wang LC; Liu LD; Gao JH; Tang DH; Wang CZ; Li QH
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1977-81. PubMed ID: 22093894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
    Lin YL; Cheng PY; Chin CL; Huang LM; Lin SY; Chiang BL
    Vaccine; 2018 Jul; 36(29):4331-4338. PubMed ID: 29891349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.
    Klein MH
    Expert Rev Vaccines; 2015 Mar; 14(3):337-40. PubMed ID: 25536888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
    Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
    Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress on the research and development of human enterovirus 71 (EV71) vaccines.
    Liang Z; Mao Q; Gao F; Wang J
    Front Med; 2013 Mar; 7(1):111-21. PubMed ID: 23247645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges to licensure of enterovirus 71 vaccines.
    Lee MS; Tseng FC; Wang JR; Chi CY; Chong P; Su IJ
    PLoS Negl Trop Dis; 2012; 6(8):e1737. PubMed ID: 22953003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses.
    Liang H; Xiao X; Zhang X; Hu Q; Yang Y; Cen S; Deng X; Sheng W
    Biochem Biophys Res Commun; 2019 Apr; 511(2):253-259. PubMed ID: 30777330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development.
    Chang JY; Chang CP; Tsai HH; Lee CD; Lian WC; Ih-Jen-Su ; Sai IH; Liu CC; Chou AH; Lu YJ; Chen CY; Lee PH; Chiang JR; Chong PC
    Vaccine; 2012 Jan; 30(4):703-11. PubMed ID: 22142585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
    Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
    Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.